Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$758M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$460M |
| 3 |
Adobe
ADBE
|
+$352M |
| 4 |
Intercontinental Exchange
ICE
|
+$327M |
| 5 |
Ferguson
FERG
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.47B |
| 2 |
Cisco
CSCO
|
+$1.1B |
| 3 |
NVIDIA
NVDA
|
+$1.01B |
| 4 |
Microsoft
MSFT
|
+$914M |
| 5 |
Apple
AAPL
|
+$753M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.36% |
| 2 | Financials | 13.6% |
| 3 | Healthcare | 11.34% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOA
3901
BioAge Labs
BIOA
$485M
| $81K | ﹤0.01% |
21,534
+6,849
| +47% | +$31.7K |
|
|
CLYM
3902
Climb Bio
CLYM
$840M
| $79.2K | ﹤0.01% |
64,914
| – | – |
|
3903
Prairie Operating Co
PROP
$83.4M
| $78.9K | ﹤0.01% |
14,741
+3,453
| +31% | +$25.2K |
|
3904
Protara Therapeutics
TARA
$234M
| $78.2K | ﹤0.01% |
18,350
+2,467
| +16% | +$11K |
|
3905
Fractyl Health
GUTS
$111M
| $76.2K | ﹤0.01% |
64,020
+22,572
| +54% | +$36K |
|
3906
Algonquin Power & Utilities
AQN
$4.43B
| $76.1K | ﹤0.01% |
14,809
+2,073
| +16% | +$9.79K |
|
3907
Key Tronic
KTCC
$42.7M
| $72.9K | ﹤0.01% |
28,237
-1
| -0% | -$3 |
|
|
MODV
3908
DELISTED
ModivCare
MODV
| $72.3K | ﹤0.01% |
54,978
-309
| -0.6% | -$1.5K |
|
3909
Skye Bioscience
SKYE
$19.3M
| $71.7K | ﹤0.01% |
45,095
+187
| +0.4% | +$511 |
|
3910
Metagenomi Therapeutics
MGX
$46.5M
| $68.5K | ﹤0.01% |
50,387
+14,296
| +40% | +$34.1K |
|
3911
Cibus
CBUS
$153M
| $68.3K | ﹤0.01% |
36,508
| – | – |
|
3912
LiveWire
LVWR
$258M
| $67.3K | ﹤0.01% |
33,659
| – | – |
|
|
MRDN
3913
Meridian Holdings Inc
MRDN
$178M
| $64.2K | ﹤0.01% |
2,717
-669
| -20% | -$16.2K |
|
|
PYN
3914
DELISTED
PIMCO New York Municipal Income Fund III
PYN
| $63.7K | ﹤0.01% |
11,292
-17
| -0.2% | -$98 |
|
|
AKYA
3915
DELISTED
Akoya BioSciences
AKYA
| $62.9K | ﹤0.01% |
45,220
-5,445
| -11% | -$11.9K |
|
3916
Galectin Therapeutics
GALT
$347M
| $62K | ﹤0.01% |
50,826
| – | – |
|
3917
Werewolf Therapeutics
HOWL
$18.9M
| $60.7K | ﹤0.01% |
62,407
-8,893
| -12% | -$11.6K |
|
3918
MarketWise
MKTW
$54.3M
| $60.6K | ﹤0.01% |
6,139
-61
| -1% | -$730 |
|
3919
Roadzen
RDZN
$117M
| $59.8K | ﹤0.01% |
57,456
+20,902
| +57% | +$28.1K |
|
3920
AirSculpt Technologies
AIRS
$244M
| $59.5K | ﹤0.01% |
25,501
+25
| +0.1% | +$112 |
|
|
GBIO
3921
DELISTED
Generation Bio
GBIO
| $56.6K | ﹤0.01% |
13,978
-13
| -0.1% | -$91 |
|
3922
Southland Holdings
SLND
$30.2M
| $56.3K | ﹤0.01% |
18,834
| – | – |
|
3923
Acrivon Therapeutics
ACRV
$78.8M
| $56.1K | ﹤0.01% |
27,635
| – | – |
|
3924
LanzaTech
LNZA
$68.4M
| $55.9K | ﹤0.01% |
2,309
| – | – |
|
3925
ALX Oncology
ALXO
$272M
| $55.6K | ﹤0.01% |
89,199
-804
| -0.9% | -$965 |
|
Similar funds
Bank of New York Mellon's Q1 2025 Portfolio in Review
As of Q1 2025, Bank of New York Mellon held 4,232 positions worth $505B, down 6.7% from $541B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of New York Mellon withdrew a net $15.2B in Q1 2025, closing 122 positions and reducing 2,490 holdings. Its most notable exit was Invesco S&P 500 Pure Value ETF, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in BNY Mellon Dynamic Value ETF worth $138M.
- Bank of New York Mellon's largest Q1 2025 buy was BNY Mellon Dynamic Value ETF: 5,452,259 shares worth $138M.
- Bank of New York Mellon added most to Johnson & Johnson in Q1 2025, an estimated $758M increase.
- Bank of New York Mellon's biggest Q1 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.47B.
- Bank of New York Mellon fully exited Invesco S&P 500 Pure Value ETF in Q1 2025, selling an estimated $123M.
- Bank of New York Mellon's ten largest holdings make up 23% of its $505B portfolio in Q1 2025.
- Bank of New York Mellon opened 116 new positions and closed 122 in Q1 2025.
- Bank of New York Mellon's portfolio value fell 6.7% quarter-over-quarter to $505B.
Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.